Alastair Clemow joins Medgenics' board
This article was originally published in Clinica
Executive Summary
Israeli firm Medgenics has appointed Alastair Clemow to its board of directors. He will fill the seat left vacant by the death of Lord Leonard Steinberg last November (www.clinica.co.uk, 10 November 2009). Dr Clemow worked for Johnson & Johnson from 1981 until 2000 in various positions, including vice-president of worldwide business development for its Ethicon Endo-Surgery unit, and director of research and development in J&J's orthopaedic division. He has also been president and CEO of spinal specialists Gelifex and Nexgen Spine, and currently holds the same positions at Israeli tissue repair company Regentis Biomaterials. Misgav-based Medgenics' lead product is the Epodure Biopump, which is designed to deliver therapeutic proteins. It is currently in a Phase I/II trial where it is being used to manufacture erythropoietin in anaemia patients.